PathogenDx Receives Investment from Salveo Capital

PathogenDx, a Tucson, Arizona-based provider of DNA-based pathogen testing kits for the cannabis, botanical, food and agriculture industries, received a minority equity investment from Salveo Capital, an alternative investment firm specializing in the legalized cannabis space.

The financial terms of the deal were not disclosed.

The company intends to use the funds to expand into new markets.

Founded in 2014 by Milan Patel, Chief Executive Officer, PathogenDx delivers testing technology and solutions to the cannabis, botanical, food and agricultural testing markets. The company’s technology offers growers, processors, producers, consumers and ancillary service providers within the botanical, food and agricultural markets real-time data and information pertaining to the quality of their product.
The technology provides customers with access to accurate real-time answers to determine if their plants or crops have been contaminated with fungi, molds, viruses or mildew.
PathogenDx’s testing can be scaled for testing facilities of all sizes from an individual plant to large agricultural fields.



Join the discussion